| Volume: | 2,044,950 |
|---|---|
| Day's Low: | $44.25 |
| 52-wk Low: | $29.96 |
| Previous Close: | $44.93 |
| Dividend: | $0.59 |
| Market Cap: | 65,131,000 |
| Avg Volume: | 1,492,400 |
|---|---|
| Day's High: | $45.02 |
| 52-wk High: | $47.61 |
| Open Price: | $44.28 |
| Yield: | 2.62% |
| P/E (Forward): | 7.03 |
| 4:18 PM | 11/5/2009 | Wall St Firms Shouldn't Get Scarce Flu Shots, Nonprofit Says |
| 5:57 AM | 11/5/2009 | UPDATE: BTG 1st Half Pretax Profit Down 25%; Eyeing Drug Buys |
| 10:13 AM | 11/3/2009 | INTERVIEW: AstraZeneca To Seek More Drug Deals In 2010 - Executive |
| 5:42 PM | 11/2/2009 | 3rd UPDATE: Conn. AG Probing Flu Vaccine Price-Fix Claims |
| 5:41 PM | 11/2/2009 | Conn AG Proving Seasonal Flu Vaccine Price-Fixing Allegations |
| 5:41 PM | 11/2/2009 | 2nd UPDATE: Conn. AG Probing Flu Vaccine Price-Fix Claims |
| 10:58 AM | 10/30/2009 | UPDATE: 1 Dose Of Pandemic H1N1 Vaccine Suitable -WHO Official |
| 11/4/2009 | Still Waiting for Details on Merck's 16,000 Job Cuts |
| 11/3/2009 | Recapping 40,000 Job Cuts in Big Pharma |
| 10/30/2009 | Yet Another Qui Tam Grand Slam |
| 10/28/2009 | Corporate Watch |
| 10/28/2009 | Agenda: Astra Zeneca Feeling Some Pain |
| 10/28/2009 | Illumina dives, Anika rallies on earnings reports |
| 10/26/2009 | Standard Chartered, Shire gain in London |
| Most Recent Quarter ($) | Same Quarter Last Year ($) | % Change | |
| EPS, Pro Forma | 1.46 | NA | NA |
| EPS, GAAP | 1.18 | 1.11 | 6.31 |
| Consensus Estimate | 1.36 | NA | NA |
| Trailing 12 Months | Year-Earlier Period | % Change | |
| EPS, Pro Forma | NA | 4.20 | NA |
| EPS, GAAP | 4.72 | 3.90 | 21.03 |
| Consensus Estimate | NA | NA | NA |
| AZN | Industry Average | |
| P/E (TTM) | 9.53 | 18.40 |
| P/E (Forward) | 7.03 | -4.30 |
| PEG Ratio | -2.34 | -0.28 |
| Price/Sales | 2.06 | 2.94 |
| Beta | 0.63 | 0.74 |